» Articles » PMID: 11673527

Transcriptional Suppression of Matrix Metalloproteinase-9 Gene Expression by IFN-gamma and IFN-beta: Critical Role of STAT-1alpha

Overview
Journal J Immunol
Date 2001 Oct 24
PMID 11673527
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Matrix metalloproteinases (MMPs) are a family of zinc-dependent endopeptidases that play crucial roles in proteolytic degradation of the extracellular matrix. Aberrant expression of the 92-kDa type IV collagenase (MMP-9) is implicated in the invasion and angiogenesis process of malignant tumors and in inflammatory diseases of the CNS. We investigated the effects of IFN-gamma and IFN-beta, cytokines used for treating some cancers and multiple sclerosis, on MMP-9 expression in human astroglioma and fibrosarcoma cell lines and primary astrocytes. Our results demonstrate that IFN-gamma and IFN-beta significantly inhibit MMP-9 enzymatic activity and protein expression that is induced by PMA and the cytokine TNF-alpha. The inhibitory effects of IFN-gamma and IFN-beta on MMP-9 expression correlate with decreased steady state MMP-9 mRNA levels and suppression of MMP-9 promoter activity. IFN-gamma- and IFN-beta-mediated inhibition of MMP-9 gene expression is dependent on the transcription factor STAT-1alpha, since IFN-gamma and IFN-beta fail to suppress MMP-9 expression in STAT-1alpha-deficient primary astrocytes and human fibrosarcoma cells. Reconstitution of human STAT-1alpha successfully restores the inhibitory effects of IFN-gamma and IFN-beta on MMP-9 gene expression. Thus, these data demonstrate the critical role of STAT-1alpha in IFN-gamma and IFN-beta suppression of MMP-9 gene expression.

Citing Articles

The Role of Twist1 in Chronic Pancreatitis-Associated Pancreatic Stellate Cells.

Geister E, Ard D, Patel H, Findley A, DeSouza G, Martin L Am J Pathol. 2024; 194(10):1879-1897.

PMID: 39032603 PMC: 11423762. DOI: 10.1016/j.ajpath.2024.06.003.


Decoding Tumor Angiogenesis for Therapeutic Advancements: Mechanistic Insights.

Kaur G, Roy B Biomedicines. 2024; 12(4).

PMID: 38672182 PMC: 11048662. DOI: 10.3390/biomedicines12040827.


Thinking outside the box: non-canonical targets in multiple sclerosis.

Bierhansl L, Hartung H, Aktas O, Ruck T, Roden M, Meuth S Nat Rev Drug Discov. 2022; 21(8):578-600.

PMID: 35668103 PMC: 9169033. DOI: 10.1038/s41573-022-00477-5.


Th17-Related Cytokines as Potential Discriminatory Markers between Neuromyelitis Optica (Devic's Disease) and Multiple Sclerosis-A Review.

Maciak K, Pietrasik S, Dziedzic A, Redlicka J, Saluk-Bijak J, Bijak M Int J Mol Sci. 2021; 22(16).

PMID: 34445668 PMC: 8396435. DOI: 10.3390/ijms22168946.


Double-edged effects of interferons on the regulation of cancer-immunity cycle.

Zhang X, Wang S, Zhu Y, Zhang M, Zhao Y, Yan Z Oncoimmunology. 2021; 10(1):1929005.

PMID: 34262796 PMC: 8253121. DOI: 10.1080/2162402X.2021.1929005.